Phase 2 Sleep Disorders Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are at least 60 years old
• People who are able to give informed consent (formally agree to take part in the study)
• People who have tried a cannabis product at least once in the past with no negative effects
• People who have not been using cannabis products regularly (fewer than 3 times per month) in the last 6 months
• Female participants must be postmenopausal (have gone through menopause)
• People whose liver function test results (specific markers called ALT and AST) are within an acceptable range for their age
• People who are currently taking medication for pain, sleep, and/or mood

Who may not be able to join:

• People who have any alcohol in their system at the screening appointment (the initial visit to sign consent forms)
• People who have used cocaine, opiates, or methamphetamine in the past 90 days, or whose urine test shows signs of these substances
• People who have a personal or family history of psychosis (a condition involving a loss of contact with reality), whether past or current
• People who are currently taking anti-epileptic medications (such as clobazam or sodium valproate)
• People who are currently taking certain medications known to interact with the study drug Epidiolex, including buprenorphine, leflunomide, levomethadyl acetate, lomitapide, mipomersen, pexidartinib, propoxyphene, sodium oxybate, and/or teriflunomide (confirm with trial site if unsure about a specific medication)
• People who are currently taking antipsychotic medications
• People who are currently undergoing chemotherapy

Important: Always verify eligibility with the trial site directly before applying.